Drug Development - Publications - Faculty & Research

Profile

Terrance McGuire

measured in multiple years rather than months. A high tech startup can see a marketplace, introduce a product and know pretty accurately whether its customers are going to purchase and use a product or service. A biotech venture might wait a decade before a promising... View Details

24 Apr 2014
News

Building a better India through business and philanthropy

more than 30 countries, Mumbai-based Piramal Group comprises companies focused on health care, life sciences, drug discovery, health care information management, financial services, specialty-glass packaging, and real estate. Recently,... View Details

23 Mar 2003
Research & Ideas

AIDS in Africa—What’s the Solution?

teachers to talk about AIDS prevention, the government can use a built-in educational infrastructure. Ngozi Edozien Ngozi Edozien, vice president of PPG Planning and Business Development for Pfizer, said the lack of a delivery... View Details

Keywords: by Julie Jette

01 Jan 2003
News

Daniel L. Vasella, M.D.

quickly," he observes. Under his guidance, Novartis has been a leader not only in developing new drugs but in making them accessible to those in need around the globe. Dan Vasella has experienced first-hand... View Details

20 Nov 2006
Research & Ideas

Open Source Science: A New Model for Innovation

innovation and product development strategies. His latest research analyzes how open source norms of transparency, permeable access, and collaboration might work with scientists. What he and his coauthors discovered:... View Details

Keywords: by Martha Lagace

Student-Profile

Olivia Zhao

pros and cons of a public system facing increased privatization. Research Olivia’s research hones in on the pharmaceutical industry and looking at the lifecycle of a drug. “It starts, of course, with research and development at huge View Details

25 Apr 2014
News

Disrupting criminal enterprises that prey on children

Kayla Brochu (MBA/JD 1999) deployed business and legal strategies to combat some of the world's worst crimes as the United Nations Office on Drugs and Crime Expert on Technology-Facilitated Child Abuse, Exploitation, and Trafficking.... View Details

08 Mar 2016
First Look

March 8, 2016

cultural model and undermine their own positions with inappropriate use of symbolic market-creation actions. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=50701 Harvard Business School Case 916-026 Express Scripts: Promoting Prescription View Details

Keywords: Sean Silverthorne

01 Jun 2018
News

The Long Run

trajectory of overdose deaths from prescription drugs and heroin. According to the Centers for Disease Control and Prevention, the US death rate from opioid overdose has increased over 400 percent since 1999; the picture is even grimmer... View Details

Keywords: Julia Hanna; photographed by Melissa Golden

Student-Profile

A Jay Holmgren

A Jay Holmgren (he/him) hadn’t yet developed a strong interest in health policy when he graduated from the University of Michigan with a BA in History in 2011. But when his father was diagnosed with cancer in 2014, A Jay found himself... View Details

08 Apr 2009
Research & Ideas

Clayton Christensen on Disrupting Health Care

An acclaimed author and expert on the development and commercialization of technological and business innovation, HBS professor Clayton Christensen has written a new book aimed at changing our national conversation about health care. In... View Details

Keywords: by Deborah Blagg; Health

01 Feb 2001
News

Q&A - Dirty Money: Raymond Baker Explores the Free Market's Demimonde

transaction prices and bank deposits — that carry stiff penalties if violated. What are the attitudes overseas about U.S. enforcement efforts? The perception is widespread in developing and transitional economies that the West, including... View Details

Keywords: Finance; Government

01 Mar 2014
News

Feedback

bulletin@hbs.edu. Write us a letter. This is your magazine. It needs your voice. Gene Williams, featured in the December 2013 HBS Alumni Bulletin Top Story The story of Gene Williams (MBA 1987) and his new drug View Details

Keywords: Health, Social Assistance

01 Dec 2018
News

Raising the Barrio

recently been the headquarters of a drug dealer known as “Tarzan.” It was a symbolic gesture, Rodríguez Larreta acknowledges, but an important one. “Our biggest obstacle was the lack of credibility. For years, [residents] have had... View Details

Keywords: April White

24 Apr 2014
News

Finding a cure so that others may benefit

call. The foundation wanted to invest in for-profit bioscience companies to spur scientists to find a cure for the disease. O’Donnell is credited with almost singlehandedly raising $250 million in support of this venture philanthropy, which led to the View Details

19 Sep 2012
Research & Ideas

Funding Innovation: Is Your Firm Doing it Wrong?

programs to an investment board comprising both insiders (senior GSK executives) and outsiders (including a venture capitalist and a biotech CEO). After a three-month review period, successful teams are awarded three years worth of investment funding. Because View Details

Keywords: by Carmen Nobel

23 Apr 2014
HBS Case

Are Electronic Cigarettes a Public Good or Health Hazard?

Drug Administration is proposing the first federal oversight of the product. The very fact users could control the amount of nicotine they ingested led to worry that e-cigarettes would cause smokers to take in more nicotine, rather than... View Details

Keywords: by Michael Blanding; Food & Beverage; Advertising

01 Mar 2017
News

How Deep Brain Stimulation Could Change Medicine

developed at Minnesota’s Mayo Clinic. Kevin Bennet (MBA 1980) chairs the hospital’s 102-year-old engineering department, where some of the first machines designed to keep patients alive during open-heart surgery were developed. Today,... View Details

Keywords: Janelle Nanos

01 Jan 2008
News

Jeffrey R. Immelt, MBA 1982

accountability, transparency, and trust; those three things will be even more important in the future.” When he was tapped to head GE in 2001, Jeff Immelt had already built an impressive nineteen-year career at the storied company that pioneered the View Details

20 Dec 2018
Research & Ideas

Most Popular Stories and Research Papers of 2018

Cirrus Foroughi, and Barbara Larson. Developing Novel Drugs This paper by Joshua Krieger and colleagues contributes to our understanding of how financing constraints affect the direction of innovation in... View Details

Keywords: by Sean Silverthorne

Publications